Hospira, Inc. (HSP) reported fourth quarter net income of $96.7 million or $0.58 per share, compared to $104.6 million or $0.65 per share last year.
Adjusted earnings per share were $0.87 for the quarter.
On average, 9 analysts polled by Thomson Reuters expected the company to report earnings of $0.69 per share. Analysts' estimates typically exclude special items.
Net sales grew to $1.06 billion from $913.7 million in the same quarter a year earlier.
Seven analysts estimated revenues of $963.45 million.
Hospira expects net sales growth for full-year 2010 to be approximately 6 to 8 percent on a constant-currency basis, excluding the projected year-over-year impact of oxaliplatin sales and business disposals. Including the impact of these items and foreign exchange, the company expects net sales to be flat to slightly up. Adjusted earnings per share for 2010 are expected to be in the range of $3.25 to $3.35. GAAP earnings per share are expected to be in the range of $2.66 - $2.76.
Analysts expect the company to earn $3.30 per share, on revenues of $3.95 billion.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.